Cargando…
TEG6s Platelet Mapping assay for the estimation of plasma fibrinogen concentration during cardiovascular surgery: a single-center prospective observational study
PURPOSE: The Activator F (ActF) test on the TEG6s Platelet Mapping assay system is a means of quantifying blood viscoelasticity caused by fibrin network formation, triggered by reptilase and factor XIII, while platelets are inhibited. This unique methodology enables the measurement of blood viscoela...
Autores principales: | Yamamoto, Yudai, Sato, Yunosuke, Takahashi, Miri, Yamamoto, Hiroto, Echizen, Mayumi, Uchida, Tokujiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807459/ https://www.ncbi.nlm.nih.gov/pubmed/34643817 http://dx.doi.org/10.1007/s00540-021-03009-4 |
Ejemplares similares
-
Evaluation of the TEG(® )platelet mapping™ assay in blood donors
por: Bochsen, Louise, et al.
Publicado: (2007) -
Coagulation support algorithm with rapid TEG and functional fibrinogen TEG in critical bleeding: more results and less time
por: Blasio, E De, et al.
Publicado: (2015) -
TEG Platelet Mapping and Impedance Aggregometry to Predict Platelet Transfusion During Cardiopulmonary Bypass in Pediatric Patients
por: Barker, Erin E., et al.
Publicado: (2019) -
TEG(®), Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy
por: Laubscher, Gert Jacobus, et al.
Publicado: (2021) -
Functional fibrinogen (FLEV-TEG) versus the Clauss method in an obstetric population: a comparative study
por: Spasiano, Alessandra, et al.
Publicado: (2019)